Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: Long-term outcome

Journal of Clinical Oncology

Volumn 29, Issue 31, 2011, Pages 4151-4159

  Ruge, Maximilian I ^a   Simon, Thorsten ^a   Suchorska, Bogdana ^b   Lehrke, Ralph ^c   Hamisch, Christina ^a   Koerber, Friederike ^a   Maarouf, Mohammad ^a   Treuer, Harald ^a   Berthold, Frank ^a   Sturm, Volker ^a   Voges, Jur̈gen ^d  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c St Barbara Hospital   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125;

ADOLESCENT; ADULT; ARTICLE; BRACHYTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CYST; FEMALE; FOLLOW UP; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SCHOOL CHILD; STEREOTACTIC BRACHYTHERAPY; STEREOTACTIC TREATMENT; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME;

ADOLESCENT; BRACHYTHERAPY; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GERMANY; GLIOMA; HUMANS; INFANT; IODINE RADIOISOTOPES; MALE; MEDICAL RECORDS; NEOPLASM GRADING; PROSPECTIVE STUDIES; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80755126832     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.3381     Document Type: Article

References (76)

1. Kaatsch P, Spix C: Annual Report 2006/07 German Childhood Cancer Registry. Mainz, 2008
2. Qaddoumi I, Sultan I, Gajjar A: Outcome and prognostic features in pediatric gliomas: A review of 6212 cases from the Surveillance, Epidemiology, and End Results database. Cancer 115:5761-5770, 2009
3. Louis DN, Ohgaki H, Wiestler OD, et al.: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109, 2007 (Pubitemid 47103521)
4. Sievert AJ, Fisher MJ: Pediatric low-grade gliomas. J Child Neurol 24:1397-1408, 2009
5. Pollack IF, Claassen D, al-Shboul Q, et al.: Low-grade gliomas of the cerebral hemispheres in children: An analysis of 71 cases. J Neurosurg 82:536-547, 1995
6. Stokland T, Liu JF, Ironside JW, et al.: A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: A population-based cohort study (CCLG CNS9702). Neuro Oncol 12:1257-1268, 2010
7. Packer RJ, Ater J, Allen J, et al.: Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86:747-754, 1997 (Pubitemid 27187674)
8. Fisher BJ, Leighton CC, Vujovic O, et al.: Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas. Int J Radiat Oncol Biol Phys 51:704-710, 2001
9. Pencalet P, Maixner W, Sainte-Rose C, et al.: Benign cerebellar astrocytomas in children. J Neurosurg 90:265-273, 1999 (Pubitemid 29068128)
10. Ronghe M, Hargrave D, Bartels U, et al.: Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem. Pediatr Blood Cancer 55:471-477, 2010
11. Gururangan S, Fisher MJ, Allen JC, et al.: Temozolomide in children with progressive low-grade glioma. Neuro Oncol 9:161-168, 2007 (Pubitemid 46580317)
12. Gururangan S, Cavazos CM, Ashley D, et al.: Phase II study of carboplatin in children with progressive low-grade gliomas. J Clin Oncol 20:2951-2958, 2002 (Pubitemid 34728889)
13. Lee MJ, Ra YS, Park JB, et al.: Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children. J Neurooncol 80:277-284, 2006 (Pubitemid 44782905)
14. Gnekow AK, Kortmann RD, Pietsch T, et al.: Low grade chiasmatic- hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy: Report from the multicenter treatment study for children and adolescents with a low grade glioma - HIT-LGG 1996 - of the Society of Pediatric Oncology and Hematology (GPOH). Klin Padiatr 216:331-342, 2004 (Pubitemid 39524567)
15. Quinn JA, Reardon DA, Friedman AH, et al.: Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol 21:646-651, 2003 (Pubitemid 46621898)
16. Massimino M, Spreafico F, Cefalo G, et al.: High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 20:4209-4216, 2002 (Pubitemid 35191023)
17. Aquino VM, Fort DW, Kamen BA: Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: A phase II study. J Neurooncol 41:255-259, 1999 (Pubitemid 29209813)
18. Beaty O 3rd, Berg S, Blaney S, et al.: A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: A Children's Oncology Group study. Pediatr Blood Cancer 55:440-445, 2010
19. Bruggers CS, Greene D: A phase 2 feasibility study of sequential, dose intensive chemotherapy to treat progressive low-grade gliomas in children. J Pediatr Hematol Oncol 29:602-607, 2007 (Pubitemid 47367995)
20. Hsu TR, Wong TT, Chang FC, et al.: Responsiveness of progressive optic pathway tumors to cisplatin-based chemotherapy in children. Childs Nerv Syst 24:1457-1461, 2008
21. Kadota RP, Kun LE, Langston JW, et al.: Cyclophosphamide for the treatment of progressive low-grade astrocytoma: A Pediatric Oncology Group phase II Study. J Pediatr Hematol Oncol 21:198-202, 1999 (Pubitemid 30306030)
22. Khaw SL, Coleman LT, Downie PA, et al.: Temozolomide in pediatric low-grade glioma. Pediatr Blood Cancer 49:808-811, 2007 (Pubitemid 47519517)
23. Laithier V, Grill J, Le Deley MC, et al.: Progression-free survival in children with optic pathway tumors: Dependence on age and the quality of the response to chemotherapy - Results of the first French prospective study for the French Society of Pediatric Oncology. J Clin Oncol 21:4572-4578, 2003 (Pubitemid 46594029)
24. Packer RJ, Jakacki R, Horn M, et al.: Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan. Pediatr Blood Cancer 52:791-795, 2009
25. Prados MD, Edwards MS, Rabbitt J, et al.: Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol 32:235-241, 1997 (Pubitemid 27077974)
26. Sawamura Y, Kamoshima Y, Kato T, et al.: Chemotherapy with cisplatin and vincristine for optic pathway/hypothalamic astrocytoma in young children. Jpn J Clin Oncol 39:277-283, 2009
27. Walter AW, Gajjar A, Reardon DA, et al.: Tamoxifen and carboplatin for children with lowgrade gliomas: A pilot study at St. Jude Children's Research Hospital. J Pediatr Hematol Oncol 22:247-251, 2000 (Pubitemid 32268309)
28. Lafay-Cousin L, Sung L, Carret AS, et al.: Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: A Canadian Pediatric Brain Tumor Consortium experience. Cancer 112:892-899, 2008 (Pubitemid 351240583)
29. Pons MA, Finlay JL, Walker RW, et al.: Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma. J Neurooncol 14:151-158, 1992
30. Packer RJ, Lange B, Ater J, et al.: Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11:850-856, 1993 (Pubitemid 23146078)
31. Merchant TE, Kun LE, Wu S, et al.: Phase II trial of conformal radiation therapy for pediatric low-grade glioma. J Clin Oncol 27:3598-3604, 2009
32. Kortmann RD, Timmermann B, Taylor RE, et al.: Current and future strategies in radiotherapy of childhood low-grade glioma of the brain: Part I. Treatment modalities of radiation therapy. Strahlenther Onkol 179:509-520, 2003 (Pubitemid 36966407)
33. Marcus KJ, Goumnerova L, Billett AL, et al.: Stereotactic radiotherapy for localized low-grade gliomas in children: Final results of a prospective trial. Int J Radiat Oncol Biol Phys 61:374-379, 2005 (Pubitemid 40164429)
34. Kano H, Kondziolka D, Niranjan A, et al.: Stereotactic radiosurgery for pilocytic astrocytomas part 1: Outcomes in adult patients. J Neurooncol 95:211-218, 2009
35. Merchant TE, Zhu Y, Thompson SJ, et al.: Preliminary results from a Phase II trail of conformal radiation therapy for pediatric patients with localised low-grade astrocytoma and ependymoma. Int J Radiat Oncol Biol Phys 52:325-332, 2002 (Pubitemid 34170841)
36. Saran FH, Baumert BG, Khoo VS, et al.: Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood. Int J Radiat Oncol Biol Phys 53:43-51, 2002
37. Tao ML, Barnes PD, Billett AL, et al.: Childhood optic chiasm gliomas: Radiographic response following radiotherapy and long-term clinical outcome. Int J Radiat Oncol Biol Phys 39:579-587, 1997
38. Fisher BJ, Bauman GS, Leighton CE, et al.: Low-grade gliomas in children: Tumor volume response to radiation. J Neurosurg 88:969-974, 1998 (Pubitemid 28261842)
39. Rutkowski S, Bode U, Deinlein F, et al.: Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352:978-986, 2005 (Pubitemid 40349500)
40. Jalali R, Mallick I, Dutta D, et al.: Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy. Int J Radiat Oncol Biol Phys 77:974-979, 2010
41. Merchant TE, Conklin HM, Wu S, et al.: Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: Prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol 27:3691-3697, 2009
42. Kortmann RD, Timmermann B, Taylor RE, et al.: Current and future strategies in radiotherapy of childhood low-grade glioma of the brain: Part II. Treatment-related late toxicity. Strahlenther Onkol 179:585-597, 2003 (Pubitemid 37101642)
43. Hug EB, Muenter MW, Archambeau JO, et al.: Conformal proton radiation therapy for pediatric low-grade astrocytomas. Strahlenther Onkol 178:10-17, 2002 (Pubitemid 34074215)
44. Schnell O, Schöller K, Ruge M, et al.: Surgical resection plus stereotactic 125I brachytherapy in adult patients with eloquently located supratentorial WHO grade II glioma: Feasibility and outcome of a combined local treatment concept. J Neurol 255:1495-1502, 2008
45. Korinthenberg R, Neuburger D, Trippel M, et al.: Long-term results of brachytherapy with temporary iodine-125 seeds in children with low-grade gliomas. Int J Radiat Oncol Biol Phys 79:1131-1138, 2011
46. Peraud A, Goetz C, Siefert A, et al.: Interstitial iodine-125 radiosurgery alone or in combination with microsurgery for pediatric patients with eloquently located low-grade glioma: A pilot study. Childs Nerv Syst 23:39-46, 2007 (Pubitemid 46138486)
47. Voges J, Sturm V, Berthold F, et al.: Interstitial irradiation of cerebral gliomas in childhood by permanently implanted 125-iodine: Preliminary results. Klin Padiatr 202:270-274, 1990 (Pubitemid 20219660)
48. Herrera EJ, Viano JC, Gómez JM, et al.: Interstitial stereotactic radiosurgery of pilocytic astrocytomas in paediatric patients. Acta Neurochir (Wien) 149:887-896, 2007; discussion 896
49. Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer, in MacLeod CM (ed): Evaluation of Chemotherapeutic Agents. New York, NY, Columbia University Press, 1949, pp 191-205
50. van Swieten JC, Koudstaal PJ, Visser MC, et al.: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604-607, 1988
51. Rankin J: Cerebral vascular accidents in patients over the age of 60: II. Prognosis. Scott Med J 2:200-215, 1957
52. Ilmberger J, Ruge M, Kreth FW, et al.: Intraoperative mapping of language functions: A longitudinal neurolinguistic analysis. J Neurosurg 109:583-592, 2008
53. Macdonald DR, Cascino TL, Schold SC Jr, et al.: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280, 1990 (Pubitemid 20195640)
54. Ruge MI, Kickingereder P, Grau S, et al.: Stereotactic biopsy combined with stereotactic (125)iodine brachytherapy for diagnosis and treatment of locally recurrent single brain metastases. J Neurooncol 2011:105, 109-118
55. Ruge MI, Kocher M, Maarouf M, et al.: Comparison of stereotactic brachytherapy (125 iodine seeds) with stereotactic radiosurgery (LINAC) for the treatment of singular cerebral metastases. Strahlenther Onkol 187:7-14, 2011
56. Ruge MI, Suchorska B, Maarouf M, et al.: Stereotactic 125iodine brachytherapy for the treatment of singular brain metastases: Closing a gap? Neurosurgery 68:1209-1219, 2011
57. Maarouf M, El Majdoub F, Bührle C, et al.: Pineal parenchymal tumors: Management with interstitial iodine-125 radiosurgery. Strahlenther Onkol 186:127-134, 2010
58. Sturm V, Pastyr O, Schlegel W, et al.: Stereotactic computer tomography with a modified Riechert-Mundinger device as the basis for integrated stereotactic neuroradiological investigations. Acta Neurochir (Wien) 68:11-17, 1983 (Pubitemid 13085271)
59. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
60. Ostertag CB: Stereotactic interstitial radiotherapy for brain tumors. J Neurosurg Sci 33:83-89, 1989
61. Ostertag CB, Kreth FW: Iodine-125 interstitial irradiation for cerebral gliomas. Acta Neurochir (Wien) 119:53-61, 1992 (Pubitemid 23022768)
62. Ostertag CB: Brachytherapy: Interstitial implant radiosurgery. Acta Neurochir Suppl (Wien) 58:79-84, 1993
63. Etou A, Mundinger F, Mohadjer M, et al.: Stereotactic interstitial irradiation of diencephalic tumors with iridium 192 and iodine 125: 10 years follow-up and comparison with other treatments. Childs Nerv Syst 5:140-143, 1989 (Pubitemid 19161304)
64. Voges J, Treuer H, Schlegel W, et al.: Interstitial irradiation of cerebral gliomas with stereotactically implanted iodine-125 seeds. Acta Neurochir Suppl (Wien) 58:108-111, 1993
65. Voges J, Sturm VV: Interstitial irradiation with stereotactically implanted I-125 seeds for the treatment of cerebral glioma. Crit Rev Neurosurg 9:223-233, 1999
66. Kreth FW, Faist M, Warnke PC, et al.: Interstitial radiosurgery of low-grade gliomas. J Neurosurg 82:418-429, 1995
67. Kreth FW, Faist M, Grau S, et al.: Interstitial 125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults: Long-term results and prognostic factors. Cancer 106:1372-1381, 2006 (Pubitemid 43363917)
68. Grill J, Couanet D, Cappelli C, et al.: Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol 45:393-396, 1999 (Pubitemid 29120046)
69. Kestle JR, Hoffman HJ, Mock AR: Moyamoya phenomenon after radiation for optic glioma. J Neurosurg 79:32-35, 1993 (Pubitemid 23182740)
70. Treuer H, Klein D, Maarouf M, et al.: Accuracy and conformity of stereotactically guided interstitial brain tumour therapy using I-125 seeds. Radiother Oncol 77:202-209, 2005 (Pubitemid 41682388)
71. Gutin PH, Prados MD, Phillips TL, et al.: External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2. Int J Radiat Oncol Biol Phys 21:601-606, 1991
72. Scharfen CO, Sneed PK, Wara WM, et al.: High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 24:583-591, 1992
73. Laperriere NJ, Leung PM, McKenzie S, et al.: Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41:1005-1011, 1998 (Pubitemid 28377480)
74. Selker RG, Shapiro WR, Burger P, et al.: The Brain Tumor Cooperative Group NIH Trial 87-01: A randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51:343-355, 2002; discussion 355-357
75. Hargrave D: Paediatric high and low grade glioma: The impact of tumour biology on current and future therapy. Br J Neurosurg 23:351-363, 2009
76. Lazzareschi I, Ruggiero A, Riccardi R, et al.: Hypersensitivity reactions to carboplatin in children. J Neurooncol 58:33-37, 2002 (Pubitemid 34711968)